Effects of Sedatives on Sublingual Microcirculation of Patients With Septic Shock

This study has been completed.
Information provided by (Responsible Party):
Guilherme Loures Penna, Casa de Saúde São José
ClinicalTrials.gov Identifier:
First received: June 11, 2012
Last updated: June 12, 2012
Last verified: June 2012
Previous studies have demonstrated that altered microvascular blood flow is an important marker of severe sepsis. Usually, these patients need invasive ventilatory support, frequent use of sedatives and it is unknown if these agents interfere or not on microvascular blood flow. The goal of this study was to compare effects of propofol and midazolam infusions on sublingual microcirculation of septic shock patients.

Condition Intervention
Drug: Sedation drug (Propofol and Midazolam)

Study Type: Interventional
Study Design: Endpoint Classification: Pharmacodynamics Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: Effects of Sedatives on Sublingual Microcirculation of Patients With Septic Shock

Resource links provided by NLM:

Further study details as provided by Casa de Saúde São José:

Primary Outcome Measures:
  • Sublingual Microcirculatory Variables [ Time Frame: Just before stopping propofol and thirty minutes after the start of midazolam infusion ] [ Designated as safety issue: No ]
    Patients were sedated with propofol during the first 24 hours after intubation and with midazolam afterwards.Systemic hemodynamics and perfusion parameters were assessed at two time points: just before stopping propofol and thirty minutes after the start of midazolam infusion. At both steps, four microcirculatory sequences were acquired using sidestream darkfield imaging to access sublingual microcirculation

Enrollment: 16
Study Start Date: March 2011
Study Completion Date: August 2011
Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Sedation drug (Propofol and Midazolam)
    Septic patients, after intubation, were initially sedated with propofol. During the second day of mechanical ventilation, propofol infusion was interrupted. When the patient awoke, the sedative drug was changed to midazolam. Sedation target was a Ramsay Scale score of 4 to 5.

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Septic shock patients needing mechanical ventilation in pressure or volume-controlled mode.

Exclusion Criteria:

  • age less than 18 years,
  • pregnancy,
  • non-sinus rhythm, and
  • contraindication of daily interruption of sedative drug,
  • mainly with the use of neuromuscular blocking drugs, or
  • patients with intracranial hypertension or epileptical status.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01618396

Casa de Saude Sao Jose
Rio de Janeiro, Brazil, 22271-080
Sponsors and Collaborators
Casa de Saúde São José
Principal Investigator: Guilherme Penna, MD, MsC State University of Rio de Janeiro
  More Information

Responsible Party: Guilherme Loures Penna, Principal Investigator, Casa de Saúde São José
ClinicalTrials.gov Identifier: NCT01618396     History of Changes
Other Study ID Numbers: CSSJ001
Study First Received: June 11, 2012
Last Updated: June 12, 2012
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by Casa de Saúde São José:
Hypnotics and Sedatives,

Additional relevant MeSH terms:
Pathologic Processes
Hypnotics and Sedatives
Adjuvants, Anesthesia
Anesthetics, General
Anesthetics, Intravenous
Anti-Anxiety Agents
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents

ClinicalTrials.gov processed this record on November 27, 2015